glp-1 microbiome Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy GLP‐1 agonists and the gut

We prioritize these standards in every product we create

Inulin consumption not only promoted weight loss but was also associated with greater loss of triglyceride in the liver (IHCL) and soleus muscle (IMCL-S), even after controlling for differences in weight lost

Some GLP-1R agonists, like Liraglutide (taken once daily) or Dulaglutide (taken once weekly), are already licensed for T2D and obesity management in humans due to their ability to mimic the effects of GLP-1 16,17,18

Company Market Share Analysis 2023 40 11.1.1

Precision is the name of the game here

The short answer is: yes, and often with synergistic benefits